Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Anti-Cancer Agents in Medicinal Chemistry|February 21, 2012
Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasisXu Wang, Wantao ChenHistology and Histopathology|June 13, 2015
The clinical translational potential of p53-related alterations as cancer biomarkersMeng Xiao, Xu Wang, Wantao ChenCancer Biotherapy & Radiopharmaceuticals|March 2, 2011
Enhancing radiosensitivity of human pulmonary adenocarcinoma cell line A549 by CpG ODN1826Rongrong Li, Yipeng Song, Wantao ChenExpert Review of Molecular Diagnostics|April 4, 2012
Epigenetic and genetic alterations-based molecular classification of head and neck cancerZhien Feng, Qin Xu, Wantao ChenThe Journal of Pharmacology and Experimental Therapeutics|April 2, 2024
Bromodomain and Extraterminal Domain Protein 2 in Multiple Human DiseasesYikang Ji, Wantao Chen, Xu WangHistology and Histopathology|September 20, 2017
Prognostic significance of PTK7 in human malignanciesGang Chen, Shengcai Qi, Xi Yang, et al.Journal of Translational Medicine|December 22, 2010
Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interferenceQin Xu, Xiuming Liu, Wantao Chen, et al.BMC Cancer|June 5, 2008
Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinomaQin Xu, Zhiyuan Zhang, Ping Zhang, et al.World Journal of Surgical Oncology|July 11, 2006
Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinomaJinzhong Li, Wantao Chen, Ping Zhang, et al.Expert Review of Molecular Diagnostics|July 12, 2016
A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarkerMeng Xiao, Xu Wang, Ming Yan, et al.Pageof 14